ebulized Dexmedetomidine and Nebulized Lidocaine in children undergoing fiberoptic bronchoscopy
Phase 3
Recruiting
- Conditions
- Broncoscopy.
- Registration Number
- IRCT20160301026866N9
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Age between 1 and 6 years, Candid for fibropetic bronchoscopy, ASAI,ASAII, Satisfaction to enter the study
Exclusion Criteria
The non-entry criteria are having any diagnosed cardiac or liver diseases, having a fever, existence of crackle or ronchi when hearing the lungs, intubation, and using other anesthetics or sedative drugs before the bronchoscopy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemodynamic effects. Timepoint: 5,10,15,20 minutes after bronchoscopy. Method of measurement: Anesthetic monitoring device.
- Secondary Outcome Measures
Name Time Method